ProKidney Corp. ( PROK) - Key Metrics
PROK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.15 | -$0.22 | -$0.24 |
| 2026Q1 | $0 | -$0.16 | -$0.29 | -$0.32 |
| 2025Q4 | $0 | -$0.14 | -$0.23 | -$0.27 |
| 2025Q3 | $0 | -$0.12 | -$0.20 | -$0.24 |
| 2025Q2 | $0 | -$0.13 | -$0.24 | -$0.26 |
PROK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.40 |
| 2026Q1 | 0% | -2.80 |
| 2025Q4 | 0% | -4 |
| 2025Q3 | 0% | -5.04 |
| 2025Q2 | 0% | -1.14 |
PROK
Price: $1.44
52 week price:
Earnings Per Share: -0.55 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 558.9 million